 Pyruvate dehydrogenase (PDH) plays key role aerobic energy metabolism occupies central crossroad glycolysis tricarboxylic acid cycle. generated inducible cardiac-specific PDH E1alpha knockout (CreER(T2)-PDH(flox/flox)) mice demonstrated high mortality rate. hypothesized PDH modulating cardiac glucose metabolism crucial heart functions normal physiological and/or stress conditions. myocardial infarction conducted ligation left anterior descending coronary arteries. Cardiac PDH E1alpha deficiency caused large myocardial infarcts size macrophage infiltration hearts (P < .01 vs wild-type [WT]). Wheat germ agglutinin Masson trichrome staining revealed significantly increased hypertrophy fibrosis PDH E1alpha-deficient hearts (P < .05 vs WT). Measurements heart substrate metabolism ex vivo working heart perfusion system demonstrated significant impairment glucose oxidation PDH E1alpha-deficient hearts ischemia/reperfusion (P < .05 vs WT). Dichloroacetate, PDH activator, increased glucose oxidation WT hearts ischemia/reperfusion reduced myocardial infarct size WT, PDH E1alpha-deficient hearts. Immunoblotting results demonstrated cardiac PDH E1alpha deficiency leads impaired ischemic AMP-activated protein kinase activation Sestrin2-liver kinase B1 interaction responsible increased susceptibility PDH E1alpha-deficient heart ischemic insults. Thus, cardiac PDH E1alpha deficiency impairs ischemic AMP-activated protein kinase signaling sensitizes hearts toxicological actions ischemic stress.